Angiographic and clinical characteristics according to intracoronary acetylcholine dose in patients with myocardial bridge

Sung Il Im, Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Sun Won Kim, Jin Oh Na, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: It is well known that myocardial bridge (MB) is a risk factor of vasospastic angina. However, clinical and angiographic characteristics according to different acetylcholine (ACh) dose in patients with MB are not clarified yet. Methods: A total 483 consecutive patients who had angiographically proven MB underwent the intracoronary ACh provocation test. ACh was injected by incremental doses of 20, 50 and 100 μg into the left coronary artery. We evaluated the clinical and angiographic characteristics of patients with MB according to 3 different ACh doses. Results: The baseline clinical and procedural characteristics are well balanced among the three groups. The MB patients who responded to the lower ACh dose (20 μg) had higher incidence of baseline spasm, severe vasospasm and diffuse long spasms (>30 mm) than those who responded to the higher doses (50 and 100 μg). The incidence of 12-month mortality and recurrent chest pain was higher in the lower ACh dose group (20 μg). Conclusion: The patients with MB significantly reacting at the low ACh dose had more pronounced baseline spasm, severe and diffuse long coronary artery spasm, higher 12-month mortality and recurrent chest pain than those reacting with the higher ACh doses, suggesting that more intensive medical therapy will be required.

Original languageEnglish
Pages (from-to)250-257
Number of pages8
JournalCardiology (Switzerland)
Volume125
Issue number4
DOIs
Publication statusPublished - 2013 Jul 1

Fingerprint

Acetylcholine
Spasm
Chest Pain
Coronary Vessels
Mortality
Incidence

Keywords

  • Acetylcholine dose
  • Myocardial bridge
  • Vasospastic angina

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

Angiographic and clinical characteristics according to intracoronary acetylcholine dose in patients with myocardial bridge. / Im, Sung Il; Rha, Seung-Woon; Choi, Byoung Geol; Choi, Se Yeon; Kim, Sun Won; Na, Jin Oh; Choi, Cheol Ung; Lim, Hong Euy; Kim, Jin Won; Kim, Eung Ju; Park, Chang Gyu; Seo, Hong Seog; Oh, Dong Joo.

In: Cardiology (Switzerland), Vol. 125, No. 4, 01.07.2013, p. 250-257.

Research output: Contribution to journalArticle

@article{6f75e7e71803434a8db37091454b901f,
title = "Angiographic and clinical characteristics according to intracoronary acetylcholine dose in patients with myocardial bridge",
abstract = "Objectives: It is well known that myocardial bridge (MB) is a risk factor of vasospastic angina. However, clinical and angiographic characteristics according to different acetylcholine (ACh) dose in patients with MB are not clarified yet. Methods: A total 483 consecutive patients who had angiographically proven MB underwent the intracoronary ACh provocation test. ACh was injected by incremental doses of 20, 50 and 100 μg into the left coronary artery. We evaluated the clinical and angiographic characteristics of patients with MB according to 3 different ACh doses. Results: The baseline clinical and procedural characteristics are well balanced among the three groups. The MB patients who responded to the lower ACh dose (20 μg) had higher incidence of baseline spasm, severe vasospasm and diffuse long spasms (>30 mm) than those who responded to the higher doses (50 and 100 μg). The incidence of 12-month mortality and recurrent chest pain was higher in the lower ACh dose group (20 μg). Conclusion: The patients with MB significantly reacting at the low ACh dose had more pronounced baseline spasm, severe and diffuse long coronary artery spasm, higher 12-month mortality and recurrent chest pain than those reacting with the higher ACh doses, suggesting that more intensive medical therapy will be required.",
keywords = "Acetylcholine dose, Myocardial bridge, Vasospastic angina",
author = "Im, {Sung Il} and Seung-Woon Rha and Choi, {Byoung Geol} and Choi, {Se Yeon} and Kim, {Sun Won} and Na, {Jin Oh} and Choi, {Cheol Ung} and Lim, {Hong Euy} and Kim, {Jin Won} and Kim, {Eung Ju} and Park, {Chang Gyu} and Seo, {Hong Seog} and Oh, {Dong Joo}",
year = "2013",
month = "7",
day = "1",
doi = "10.1159/000351181",
language = "English",
volume = "125",
pages = "250--257",
journal = "Cardiology",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Angiographic and clinical characteristics according to intracoronary acetylcholine dose in patients with myocardial bridge

AU - Im, Sung Il

AU - Rha, Seung-Woon

AU - Choi, Byoung Geol

AU - Choi, Se Yeon

AU - Kim, Sun Won

AU - Na, Jin Oh

AU - Choi, Cheol Ung

AU - Lim, Hong Euy

AU - Kim, Jin Won

AU - Kim, Eung Ju

AU - Park, Chang Gyu

AU - Seo, Hong Seog

AU - Oh, Dong Joo

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Objectives: It is well known that myocardial bridge (MB) is a risk factor of vasospastic angina. However, clinical and angiographic characteristics according to different acetylcholine (ACh) dose in patients with MB are not clarified yet. Methods: A total 483 consecutive patients who had angiographically proven MB underwent the intracoronary ACh provocation test. ACh was injected by incremental doses of 20, 50 and 100 μg into the left coronary artery. We evaluated the clinical and angiographic characteristics of patients with MB according to 3 different ACh doses. Results: The baseline clinical and procedural characteristics are well balanced among the three groups. The MB patients who responded to the lower ACh dose (20 μg) had higher incidence of baseline spasm, severe vasospasm and diffuse long spasms (>30 mm) than those who responded to the higher doses (50 and 100 μg). The incidence of 12-month mortality and recurrent chest pain was higher in the lower ACh dose group (20 μg). Conclusion: The patients with MB significantly reacting at the low ACh dose had more pronounced baseline spasm, severe and diffuse long coronary artery spasm, higher 12-month mortality and recurrent chest pain than those reacting with the higher ACh doses, suggesting that more intensive medical therapy will be required.

AB - Objectives: It is well known that myocardial bridge (MB) is a risk factor of vasospastic angina. However, clinical and angiographic characteristics according to different acetylcholine (ACh) dose in patients with MB are not clarified yet. Methods: A total 483 consecutive patients who had angiographically proven MB underwent the intracoronary ACh provocation test. ACh was injected by incremental doses of 20, 50 and 100 μg into the left coronary artery. We evaluated the clinical and angiographic characteristics of patients with MB according to 3 different ACh doses. Results: The baseline clinical and procedural characteristics are well balanced among the three groups. The MB patients who responded to the lower ACh dose (20 μg) had higher incidence of baseline spasm, severe vasospasm and diffuse long spasms (>30 mm) than those who responded to the higher doses (50 and 100 μg). The incidence of 12-month mortality and recurrent chest pain was higher in the lower ACh dose group (20 μg). Conclusion: The patients with MB significantly reacting at the low ACh dose had more pronounced baseline spasm, severe and diffuse long coronary artery spasm, higher 12-month mortality and recurrent chest pain than those reacting with the higher ACh doses, suggesting that more intensive medical therapy will be required.

KW - Acetylcholine dose

KW - Myocardial bridge

KW - Vasospastic angina

UR - http://www.scopus.com/inward/record.url?scp=84879478247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879478247&partnerID=8YFLogxK

U2 - 10.1159/000351181

DO - 10.1159/000351181

M3 - Article

C2 - 23816809

AN - SCOPUS:84879478247

VL - 125

SP - 250

EP - 257

JO - Cardiology

JF - Cardiology

SN - 0008-6312

IS - 4

ER -